Metacrineincis A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniafounded In 2014The Company Focuses On Developing Therapies For Gastrointestinal And Liver Diseases Using Its Proprietary Chemistry And Biology Platformit Targets The Farnesoid X Receptorfxr Which Plays A Key Role In Bile Acid Metabolisminflammationand Fibrosis The Company S Pipeline Includes Met642A Next Generation Fxr Agonist For Inflammatory Bowel Diseasewhich Has Completed Phase I Trialsadditionallymetacrine Is Working On The Hsd17B13 Programaimed At Treating Non Alcoholic Steatohepatitis And Other Liver Diseaseswith A Library Of Around 2 500 Fxr Compoundsmetacrine Is Positioned To Discover Differentiated Drug Candidates That Address Chronic Liver Diseases And Gastrointestinal Disorders
No conferences found for this company.
| Company Name | Metacrine Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
